Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Embla Medical

27.60 DKK

-2.82 %

Less than 1K followers

EMBLA

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
-2.82 %
-8.91 %
-15.08 %
-17.37 %
-6.44 %
-4.50 %
-16.49 %
-36.55 %
+401.82 %

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.

Read more
Market cap
11.88B DKK
Turnover
2.85M DKK
Revenue
EBIT %
P/E
Dividend yield-%
Coverage
Disclaimer
Michael Friis
Michael Friis

Head of Equities

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28.4.
2026

Interim report Q1'26

21.7.
2026

Interim report Q2'26

20.10.
2026

Interim report Q3'26

All
Research
Webcasts
Press releases
3rd party
ShowingAll content types
Regulatory press release7 hours ago

Embla Medical hf.: Embla Medical hf: Registration of capital reduction of 2,441,257 shares completed

Embla Medical
Regulatory press release3/10/2026, 1:00 PM

Embla Medical hf.: Embla Medical hf: Results of the Annual General Meeting 2026

Embla Medical
Regulatory press release3/9/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release3/5/2026, 6:00 AM

Embla Medical hf.: Embla Medical hf: Candidates to the Board of Directors

Embla Medical
Regulatory press release3/2/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release2/24/2026, 6:00 AM

Embla Medical hf.: Embla Medical hf: Final Agenda and Proposals for the 2026 Annual General Meeting

Embla Medical
Regulatory press release2/23/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release2/17/2026, 6:00 AM

Embla Medical hf.: Embla Medical hf: Notice to 2026 Annual General Meeting

Embla Medical
Regulatory press release2/16/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release2/9/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Embla Medical: Recording of FY 2025 results presentation
Analyst Comment2/3/2026, 1:59 PM by
Michael Friis

Embla Medical: Recording of FY 2025 results presentation

Today, Embla Medical’s CEO, Sveinn Sölvason, presented the FY 2025 results and outlined the key drivers behind the expectations for 2026. These expectations underline a stable structural growth case and are well aligned with the company’s mid-term 2027 targets.

Embla Medical
Regulatory press release2/3/2026, 6:05 AM

Embla Medical hf.: Embla Medical Publishes 2025 Annual Report; CEO Highlights Solid Progress and Strategic Momentum

Embla Medical
Regulatory press release2/3/2026, 6:00 AM

Embla Medical hf.: Embla Medical hf: Interim Report Q4 and Full Year 2025

Embla Medical
Regulatory press release2/2/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release1/26/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release1/19/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Regulatory press release1/12/2026, 4:00 PM

Embla Medical hf.: Embla Medical hf: Transactions in relation to Share Buyback Program

Embla Medical
Press release1/9/2026, 6:00 AM

Embla Medical hf.: Embla Medical hf: Conference call details for Q4/FY 2025

Embla Medical
Regulatory press release12/23/2025, 4:30 PM

Embla Medical hf.: Embla Medical hf: Initiating New Share Buyback Program

Embla Medical
Regulatory press release12/23/2025, 4:00 PM

Embla Medical hf.: Embla Medical hf: Share Buyback Program Completed

Embla Medical
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.